TABLE 2.
Demographic and clinical characteristics of study subjects
| Test groups | |||||
|---|---|---|---|---|---|
| Characteristics | Infuza (n = 52) | Kulzam (n = 51) | Infuza and Kulzam (n = 51) | Control (n = 53) | p‐value |
| Average age; years (mean ± SEM) (range) | 29.8 ± 0.98 (21–50) | 31.5 ± 1.4 (20–53) | 29.7 ± 0.10 (18–52) | 31.6 ± 1.5 (18–62) | >.05 |
| Male (%) | 61.5 | 58.8 | 58.8 | 54.7 | — |
| Female (%) | 38.5 | 41.2 | 41.2 | 45.3 | — |
| BMI; kg/m2 (mean ± SEM) | 23.2 ± 0.61 | 23.7 ± 0.51 | 24.2 ± 0.57 | 22.9 ± 0.46 | >.05 |
| Systolic blood pressure (mean ± SEM [mmHg]) | 112.9 ± 0.78 | 113.2 ± 0.75 | 113.6 ± 0.67 | 114.2 ± 0.71 | >.05 |
| Diastolic blood pressure (mean ± SEM [mmHg]) | 81.0 ± 0.91 | 81.7 ± 0.78 | 81.8 ± 0.64 | 81.7 ± 0.78 | >.05 |
| Pulse rate (mean ± SEM [BPM]) | 76.6 ± 0.67 | 78.0 ± 0.73 | 77.5 ± 0.62 | 78.2 ± 0.72 | >.05 |
| Oxygen saturation (%) (mean ± SEM) | 97.3 ± 0.22 | 97.2 ± 0.21 | 98.2 ± 0.10 | 97.2 ± 0.23 | >.05 |
| Any co‐morbidities | Nil | Nil | Nil | Nil | — |
| Direct contact with COVID‐19 positive patients (n [%]) | 40 (76.9) | 44 (86.3) | 40 (78.4) | 41 (77.4) | >.05 |
| Healthcare workers/others | 12 (23.1) | 07 (13.7) | 11 (21.6) | 12 (22.6) | >.05 |
| Average time from exposure to enrolment (days) (mean ± SEM) | 3.6 ± 0.31 | 3.6 ± 0.20 | 3.1 ± 0.19 | 3.5 ± 0.23 | >.05 |
| Subject(s) turned positive after enrollment in study (% [n]) | 7.69 (4)* | 3.92 (2)** | 1.96 (1)*** | 15.09 (8) | .233* |
| .533** | |||||
| .017*** | |||||
Note: Data are expressed as number, percentage and mean ± SEM. The continuous and categorical variables are analysed by unpaired “t” test and “Z” test of two proportion, respectively as compared to control group. *, **, *** Statistical comparison of Infuza, Kulzam and in combination of Infuza and Kulzam groups, respectively with control group. (p < .05: significant difference, p > .05: not significant).
Abbreviation: BPM; beats per minute.